1-(2-Chloroacetyl)-4-methyl-piperazine hydrochloride, 98.0%, 25g

1-[(1R,2S,4R)Bicyclo[2.2.1]hept-5-en-2-yl] methaneamine oxalate, 95.0%, 250mg

3-Hydroxy-1H-pyrazole-4-carboxylic acid ethyl ester, 95.0%, 5g

4-BROMO-2-METHOXY-5-NITROANILINE, 95.0%, 5g

Vinylmethylsiloxane-dimethylsiloxane copolymer, trimethylsiloxy terminated cSt 250-350, 1kg

N-Benzyloxycarbonyl-L-isoleucine dicyclohexylamine salt, 97%, 500g

Sal tetrasódica de EDTA dihidrato, mínimo 99 %, 500 g, envase de plástico.

(2E)-1-(2,5-dimethoxyphenyl)-3-(3-fluorophenyl)prop-2-en-1-one, 95.0%, 10g

Ethyl 6-chloro-2-methylimidazo[1,2-a]pyridine-3-carboxylate, 95.0%, 10g

LSD Inhibitor S1024>98.0%(HPLC)(qNMR)25mg

5-Methyloxazole, 95.0%, 5g

Metanol, mínimo 99%, para síntesis, 2,5 l, envase de plástico.

Virutas de magnesio 99,5% 2-5 mm 1 g